Related Experiment Videos
Cardiovascular effects of rectal methohexital in children
S M Audenaert1, R L Lock, G L Johnson
1Department of Anesthesiology, University of Louisville, KY.
Insights
Rectal methohexital effectively induces sleep in pediatric patients, causing a slight increase in heart rate and a decrease in stroke volume. Cardiovascular side effects were minimal in children with normal cardiac function.
Area of Science:
- Pediatric Anesthesiology
- Cardiovascular Physiology
- Pharmacology
Background:
- Rectal methohexital is used for procedural sedation in children.
- Understanding its cardiovascular effects is crucial for patient safety.
- Previous studies have not fully defined these effects in healthy pediatric patients.
Purpose of the Study:
- To determine the cardiovascular effects of rectal methohexital in children.
- To assess changes in heart rate, blood pressure, and cardiac function.
- To evaluate safety in pediatric patients with normal cardiac function.
Main Methods:
- A prospective study involving 47 children undergoing elective surgery.
- Cardiovascular parameters (heart rate, blood pressure, echocardiography) were measured before and after rectal methohexital administration.
- Rectal methohexital was administered at 30 mg/kg, with an optional additional 15 mg/kg if needed.
Main Results:
- Heart rate significantly increased (126 to 144 bpm, p < 0.001).
- Stroke volume decreased (24 ml to 21 ml, p < 0.01).
- No significant changes in blood pressure or cardiac index were observed; ejection fraction remained normal.
Conclusions:
- Rectal methohexital is a safe sedative agent for pediatric patients.
- The primary cardiovascular effects observed were increased heart rate and decreased stroke volume.
- These changes were within acceptable limits for children with normal cardiac function.
Study Objective:
To define the cardiovascular effects of rectal methohexital in children with normal cardiac function.
Design:
Cardiovascular evaluation of each patient was performed before and after medication. Each patient's predrug results were used as control measurements for comparison with measurements made after methohexital administration.
Setting:
Inpatient operating room induction area in a privately endowed philanthropic children's hospital.
Patients:
Forty-seven children age 35 +/- 22 months (mean +/- SD) scheduled for elective orthopedic or plastic surgery, free of cardiac or pulmonary disease, and receiving no medication with central nervous system activity.
Interventions:
Control measurements of heart rate (HR), blood pressure (BP), and echocardiographic evaluations were obtained on the day before scheduled surgery. Repeat measurements were performed after the onset of methohexital-induced sleep. The time span of the measurements was designed to include the period of peak plasma methohexital concentration. In the preoperative holding area, 30 mg/kg of a 10% methohexital solution was administered rectally. If sleep did not occur in 15 minutes, an additional 15 mg/kg was given.
Measurements And Main Results:
HR increased markedly after rectal methohexital [126 +/- 23 beats per minute (bpm) to 144 +/- 21 bpm, p less than 0.001], and stroke volume (SV) decreased (24 +/- 9 ml to 21 +/- 8 ml, p less than 0.01). There were no significant changes in BP or cardiac index. The shortening fraction and ejection fraction remained within the normal range for this age-group.
Conclusions:
Rectal methohexital induces sleep in healthy pediatric patients with minimal cardiovascular side effects. The primary effects are increased HR and decreased SV.